This disclosure pertains to intravascular medical devices for retracting blood clots from blood vessels in the human body. The same system may be used to remove obstructions from ducts and other cavities of the body, such as, for example, foreign bodies or stones from the urinary or the biliary tracts.
The present disclosure addresses several challenges with current thrombectomy procedures in high risk deep vein thrombosis (DVT) and pulmonary embolism (PE) populations, as well as ischemic stroke (IS) patients.
The present disclosure may be able to capture both hard and soft clots, it may be able to collect large clots in a single pass, rather than relying upon the lengthy and uncontrolled infusion of thrombolytic drugs with potential side effects, it may do so without trauma to the vessel or duct, it may significantly reduce blood loss which can be substantial with other devices, it may be able to reduce or completely eliminate the potential for distal embolization by capturing all of the clot for retraction and preventing release of clot fragments distal to the clot, the catheter system may be substantial smaller making vascular access easier and more rapid, and it may be significantly simpler and more rapid to operate than existing thrombectomy devices.
The present disclosure describes a medical device capable of retracting thrombus or another obstacle from blood vessels or other lumens. According to the disclosure, the thrombectomy device retracts the thrombus towards the catheter. It can optionally be equipped with a collecting mechanism and/or aspiration. Once the clot has been drawn into the guiding catheter, the retraction device and clot are withdrawn proximally through the guiding catheter out of the body.
One aspect of the present disclosure is to provide a mechanical thrombectomy system that is small and flexible enough that it can reliably and safely navigate tortuous blood vessels to the site of a thrombus.
A second aspect of the present disclosure is to provide a mechanical thrombectomy device that can reliably and securely entrap a soft or hard thrombus without fragmenting the thrombus or damaging the intima of the blood vessel.
A third aspect of this disclosure is to provide a mechanical thrombectomy device that is biocompatible and compatible with standard medical catheters.
A fourth aspect of this disclosure is to provide a mechanical thrombectomy device that is visible on X-ray, and/or MR imaging, and/or Ultrasound. In addition, fiber optic technology (FOSS, Fiber Optic Shape Sensing) can be embedded to support 3D visualization of the shape and location of the device without any external imaging.
A fifth aspect of the present disclosure is to integrate hemo-compatible materials to improve catheter tip navigability and vascular access.
A sixth aspect of the disclosure is to provide a mechanical thrombectomy device that reduces the risk of fragmentation and distal embolization.
A seventh aspect of the disclosure is to provide aspiration through the guiding catheter, and also through the collecting catheter if it is used to decrease clot fragment embolization, to remove soft components of the thrombus, and to decrease the size of the retracted thrombus to facilitate its removal through the guiding catheter.
An eighth aspect of this disclosure is that the thrombectomy device is pre-loaded within the retraction catheter for easy use.
A ninth aspect of this disclosure is that the retraction catheter has multiple lumens, including one for a pre-loaded thrombectomy device and another one for a guidewire.
The disclosure will be described in relation to the following exemplary and non-exclusive illustrations in which similar elements are numbered similarly, and where:
The drawings are exemplary and non-limiting and intended to cover modifications, equivalents, and alternatives covered within the scope of the disclosure.
The thrombectomy devices disclosed in this disclosure generally use a web structure with the aid of retraction wires to reliably retract thrombus and other obstructions in blood vessels and body ducts. The device includes expandable struts having a closed compact configuration and an open expanded configuration. In optional embodiments, additional functionality may be optionally included.
A collecting catheter 130 may be optionally included. Collecting catheter 130 may pass through guiding catheter 120 and may be placed just below the proximal aspect of clot 110. Collection catheter 130 and guiding catheter 120 may be concentric or non-concentric. In one embodiment, guidewire 140 can be placed distal to thrombus 110 as shown in
In one embodiment, the thrombectomy device with retracting wire 160, struts 170, ring structure 180 and web 190 may extend, and pass through, retraction catheter 150. In another embodiment, retracting wire 160, struts 170, ring structure 180 and web 190 may be pre-loaded inside the retraction catheter. Guidewire 140 can be removed, as shown in
The thrombectomy device (including components 170, 180, 190) can be deployed by manipulating the retraction wire 160 as shown in
Initially, as shown in
Similar systems disclosed in the present disclosure may preferably be used to remove obstructions from ducts and other cavities of the body, such as, for example, bile or pancreatic ducts, or another foreign body. In an exemplary embodiment, a collecting basket and catheter may be used to capture such clot or object. According to an embodiment of the disclosure, any obstruction, retraction wire, and retraction catheter can be pulled into the collecting catheter or directly into the guiding catheter for removal.
Handle 700 may include a deployment and/or retraction mechanism as well as notches, indents, bumps, protrusions, and other features. The handle may also have alternative shapes or forms made out of a polymer material, a metal material, a combination of a metal material and a polymer material, or more other suitable materials. In the method of the disclosure, the thrombus, ring, and web are pulled proximally into the collecting catheter, which is then pulled out of the guiding catheter.
In one embodiment of the disclosure, the thrombectomy device including the retraction wires, struts, ring-shape and web can be pre-loaded in the retraction catheter. One advantage of having the thrombectomy device pre-loaded is that it is easier for the clinical user: there is no need to pass it through the retraction catheter, and since it can be pre-loaded at a well-defined position at the distal tip of the retraction catheter, and with the retraction catheter moved to the position distal to the thrombus, the only manipulation needed to deploy the actual thrombectomy device is to push the retraction wire(s) over a well-defined distance to deploy the thrombectomy device. This distance can be pre-set in the handle, thereby making it very reliable and user friendly, requiring minimal extra skills of the clinical user.
In another embodiment, to secure easy transfer of a guidewire through the retraction catheter without the need to physically pass next to the thrombectomy device, the retraction catheter can be equipped with multiple lumens (each of independent size as required), where one lumen can be used for the thrombectomy device (preferably ‘pre-loaded’), and another lumen can be used for a guidewire.
In another embodiment, a catheter connected to an aspiration device can be added to the manifold attached to the hub of the guiding catheter or if present the collecting catheter so that aspiration is applied to the entire system to facilitate retraction, prevent fragmentation and embolization of firm fragments, and aspiration of softer elements to facilitate clot removal through the guiding catheter.
In another embodiment, the device can be equipped with imaging sensors, or with sensors measuring physiological parameters such as pressure, temperature, oximetry.
In another embodiment, a thrombolytic or therapeutic agent can be released as part of the procedure prior, and/or during/and or immediately following the thrombectomy procedure. The agent can be released via one of the catheters that are in use for the thrombectomy procedure, or via an additional catheter passed through the guiding or collecting catheter.
In one embodiment of the disclosure, fluoroscopically visible markers are applied to the retraction ring, to the retraction wire and the collecting basket and to the tip of the guiding catheter, the collecting catheter and the retraction catheter to facilitate localization of all components.
In one embodiment, FOSS technology enables the manipulation and visualization of thrombectomy devices without the need for fluoroscopy. In addition to reducing the need for x-ray exposure of the patient and medical personnel, the FOSS technology also features improved, more accurate, easier and faster guidance by providing more detailed views of device positioning with 3D views that are difficult to achieve with fluoroscopy. In an exemplary embodiment, optical fibers are embedded in the catheters or other parts of the device, with typically 3 or more micro-optical fibers that are equipped with Fiber Bragg Gratings. This enables (by analyzing the reflected laser light coupled to the fibers) the determination in 3 dimensions of the shape and position of the catheters and wires in real-time and with high accuracy. The shape and position of the catheters and wires can then be superimposed on roadmap views of the vasculature and pathology.
Portions or the components of a thrombectomy device may also preferably include a radiopaque material capable of producing a relatively bright image on a fluoroscopy screen, or another imaging technique during a medical procedure which aids the user of the retraction thrombectomy device in determining its location. Some examples of radiopaque materials can include, but are not limited to, gold, platinum, palladium, tantalum, tungsten alloy, and polymer material loaded with a radiopaque filler. Components of the thrombectomy device may also be made from a metal, metal alloy, polymer, a metal-polymer composite, ceramics, or other suitable material. Some examples of suitable metals and metal alloys include stainless steel, such as 304V, 304L, and 316LV stainless steel; mild steel; nickel-titanium alloy such as linear-elastic and/or super-elastic nitinol; other nickel alloys such as nickel-chromium-molybdenum alloys.
According to the present disclosure, FOSS can be used to reduce or eliminate X-ray utilization and to improve guidance and visualization. In shown in
When using two devices like a FOSS guidewire running through a FOSS catheter, there is an obvious space constraint where the guidewire runs inside the catheter. The FOSS data for guidewire and catheter may be aligned with each other in post processing in order to increase spatial precision—or when the discrepancy between the calculated positions is too large, that may be used as an indication that the shape of either has a higher inaccuracy. Monitoring the distribution shape of flexible components, FOSS can provide valuable data during design, testing and operation, including potentially in vivo vascular conditions.
The thrombectomy device product may be provided in any format of packaging that protects the device and preferably keeps the device in antiseptic conditions for single sterile use. In one embodiment, a rigid polyethylene tube carrier may be inserted into a Tyvek/polyethylene pouch pre-sealed on three sides. The pouch can be heat-sealed closed with a label placed on the clear polyethylene film. A sealed pouch along with Instructions for Use may be inserted into an appropriately sized carton.
The wires used to practice the present disclosure may be produced from any number of suitable materials. Preferably, the wire may be made from a “so-called” super-elastic alloy. These alloys are characterized by an ability to transform from an austenitic crystal structure to a stress-induced martensitic structure and to return elastically to the austenitic crystal structure (and the original shape) when the stress is removed. A typical alloy is nitinol, a nickel-titanium alloy, which is commercially available and undergoes the austenite-SIM-austenite transformation at a variety of temperature ranges. In the method of this disclosure, the thrombectomy device is attached to a nitinol retraction wire and sheathed by a flexible retraction catheter. A colored positioning marker on the retraction catheter aids in proper insert placement. A handle can control the device delivery and release mechanism. The thumbwheel on the handle retracts the retraction catheter. The button allows the physician to change the function of the thumbwheel from retracting the retraction catheter to deploying the device. The introducer helps facilitate entry and advancement of the insert during insertion of the device. The retraction wire is detached from the device by continuing to rotate the thumbwheel. Symbols are located on the handle.
In an exemplary practice according to the disclosed principles, a method of imaging, including ultrasonography, computed tomographic angiography, or magnetic resonance angiography can be used to localize thrombus. Puncture of the right femoral vein located just inferior to the inguinal ligament can be performed and a standard large bore (16F or larger) intravascular sheath connected to heparinized saline can be introduced into the vein. A 16F 65 cm long guiding catheter connected to heparinized saline containing a standard 0.035″ J-tip guidewire can be introduced into the sheath. The J-tip guidewire can be pushed cephalad to just below the thrombus. The guiding catheter can be pushed cephalad, sliding smoothly along the J-wire so that its tip may be approximately 4 cm proximal to the thrombus. A 14F catheter with a 4 cm long compressed nitinol basket (the collecting device) at its distal end can be placed over the J-wire and advanced so that the basket may pass out of the distal end of the guiding catheter, opening to fill the entire lumen of the vein proximal to the thrombus. The J-guidewire is removed and both catheter systems are aspirated and then flushed with heparinized saline.
A 6F catheter may be employed with a stainless steel 0.025″ guidewire with a floppy distal end and can be passed cephalad into the collecting catheter so that its tip extends into the venous lumen, the boundaries of which are lined with the collecting system nitinol basket. In one embodiment, a small guidewire can be pushed cephalad so that it may pass between the clot and the intimal surface of the vein. The retraction catheter can then be pushed cephalad to follow over the guidewire so that its tip ends distal to (above) the thrombus. The guidewire may be exchanged for the retraction device, or the retraction device may already be present pre-loaded, preferably in another lumen within the retraction catheter.
In the present disclosure, the retraction catheter and retraction wire may pull the clot into the collecting catheter, which closes tightly over the thrombus as it is pulled into the guiding catheter. When possible, the entire thrombus may be pulled into the guiding catheter and removed from the body, leaving the guiding catheter in place. If the clot is too large to be pulled into and through the guiding catheter, aspiration may be applied to the guiding catheter or the collecting catheter, wherein in an embodiment of the disclosure, a catheter connected to an aspiration system can be hooked to the flushing system for the guiding catheter via a 3-way stopcock. Aspiration can be usefully added when applied to the clot that has been pulled into the collecting device to make it smaller for removal through the guiding catheter. In a further embodiment of the disclosure, J-wires with very firm distal ends may be preferably introduced into the guiding and collecting catheters to break the clot into smaller pieces while continuous aspiration prevents the clot fragments from flowing distally. If not successful, the clot adherent to the tip of the guiding catheter, and the catheter itself, can be removed through the access sheath. Catheterization with the guiding catheter can then be repeated, as needed.
A problem often encountered during the deployment and retraction of conventional thrombectomy devices is that the device slides to one side when encountering the clot. Thus, the device is not pulled over the clot; rather, it passes in-between the clot and the vessel wall. An exemplary embodiment of the disclosure addresses this shortcoming by incorporating a so-called Aligner into the thrombectomy device.
Specifically,
The struts 1106 may pass the clot mostly on one side since that is typically the path created by the guidewire (not shown) and followed by the withdrawn extraction catheter (not shown). As a result, the problem arises in that struts 1106 will not evenly distribute over the circumference of the vessel lumen (not shown) and will typically cluster on one side of the clot 1104. This may not be a problem for soft clots assuming that when withdrawn, struts 1106 will probably cut through the clot. With the ring not collapsing, clot 1104 would be captured.
In the case of a hard clot, however, the struts cannot cut through the clot when pulled. Thus, ring 1108 and web 1110 will collapse following the path of the struts thereby passing clot 1104 on a side and leaving the clot behind.
Another practical issue addressed in the present disclosure is the accuracy of the navigational process used to direct the endovascular placement of a thrombectomy device relative to the location of a thrombus. Magnetic Resonance Imaging (“MRI”) can help localize and characterize the thrombus and optimize the positioning of the thrombectomy device. In one embodiment of the disclosure, high-speed, high-resolution MR imaging is combined with conventional X-ray fluoroscopy and digital subtraction angiography (DSA) capability in a single hybrid imaging unit. This real-time imaging capability makes it possible to use high-speed MR imaging to direct the movement of catheters and other components of the thrombectomy system to specific endovascular locations, and thereafter observe the effects of specific interventional procedures.
Magnetic Resonance Imaging. After acquiring a roadmap visualizing the vasculature and pathology, it is possible to project the position of the device in 3D. Advancing the catheter toward the thrombus and manipulating the device while extracting the thrombus can be done without the need for any additional x-ray, with better and more accurate 3D visualization, under all projections, and typically in a shorter time. The catheter tip on thrombectomy devices is difficult to see on MRI because of inadequate contrast with respect to surrounding tissues and structures. This makes accurate localization difficult and degrades the quality of the diagnostic information obtained from the image. Thus, one objective of this disclosure is to provide an MR-compatible and visible device that significantly improves the efficacy and safety of thrombus removal using MR guidance. For example, to enhance compatibility with MRI imaging systems, it may be desirable to make portions of the device in a manner that would impart a degree of MRI compatibility. For example, the device, or portions thereof, may be made of a material that does not substantially distort the image and create substantial artifacts (artifacts are gaps in the image). Certain ferromagnetic materials, for example, are not preferred in the present disclosure because they may create artifacts in an MRI image; rather, the device may be made from a material that the MRI machine can image.
Different elements of the device, including elements such as ring segments or alternatively connective eyelets of ring segments can be made visible on MRI by selecting a coating of, a core of, or an amalgam of nitinol, platinum and ferromagnetic material. Circular structures such as the ring shape can be configured in such a way that they create resonating structures excited and made visible by parts of the MRI imaging sequence.
MR imaging may also be of practical benefit in the present disclosure in assessing and in characterizing the age, composition, and size of a thrombus. A growing body of evidence suggests that a combination of MR imaging and neurologic symptoms may in fact have prognostic predictive value in assessing patient outcome. During formation of a thrombus, the blood contains a mixture of oxyhemoglobin, deoxyhemoglobin and methemoglobin that is usually equal to that of arterial blood. As the thrombus ages, however, the concentration of paramagnetic hemoglobin and methemoglobin within the clot also changes resulting in a characteristic appearance on MR images that reflects the age and stability of the clot. Observation of these MR imaging changes can be clinically useful in the method of the present disclosure in evaluating the potential utility of various alternative interventions, such as, for example, drug thrombolytic therapy and mechanical thrombectomy.
Further in the method of the disclosure, materials can be added to the structure of a pliable catheter to make it MR visible but may not contribute significantly to the overall magnetic susceptibility of the catheter, or imaging artifacts could be introduced during the MR process. In one embodiment, thrombectomy devices used under MR guidance are MR-compatible in both static and time-varying magnetic fields. Although the mechanical effects of the magnetic field on ferromagnetic devices present the greatest danger to patients through possible unintended movement of the devices, tissue and device heating may also result from radio-frequency power deposition in electrically conductive material located within the imaging volume. Consequently, in the method of the present disclosure, all cables, wires, and devices positioned within the MR imaging system must be made of materials that have properties that make them compatible with their use in human tissues during MR imaging procedures. Many materials with acceptable MR-compatibility, such as ceramics, composites and thermoplastic polymers, are electrical insulators and do not produce artifacts or safety hazards associated with applied electric fields. Some metallic materials, such as copper, brass, magnesium and aluminum are also generally MR-compatible. Guidewires for the catheter component of the thrombectomy system can usually made of radiopaque material so that their precise location can be identified during a surgical procedure through fluoroscopic viewing.
The following non-limiting examples are provided to further illustrate some embodiments of the disclosed principles. Example 1 is directed to a thrombectomy device to extract a thrombus from a body lumen, the device comprising: a retraction catheter (150) having a proximal end and a distal end, the retraction catheter configured for insertion into the body lumen; a retracting wire (160) movably positioned inside the retraction catheter, the retraction wire further comprising: a plurality of struts (170) coupled to the distal end of the retracting wire at a first end of each of the plurality of struts; a collapsible ring (180) coupled to the second end of each of the plurality of struts; and a collapsible web (190) coupled to the ring and configured to expand into a basket when extended beyond the distal end of the retraction catheter; wherein the collapsible web is configured to fold into a substantially liner structure to movably fit within the retraction catheter.
Example 2 is directed to the thrombectomy device of example 1, wherein the collapsible ring is configured to collapse into a folded state when retracted into the retraction catheter.
Example 3 is directed to the thrombectomy device of example 2, wherein in the folded state the collapsible ring is movable within the retraction catheter.
Example 4 is directed to the thrombectomy device of example 1, wherein the collapsible ring is configured to unfold to assume a substantially circular form when extended beyond the distal end of the retraction catheter.
Example 5 is directed to the thrombectomy device of example 4, wherein unfolding of the collapsible ring directs expansions of the collapsible web beyond the proximal end of the retraction catheter.
Example 6 is directed to the thrombectomy device of example 1, wherein the basket is configured to encircle a clot (110) within the body lumen.
Example 7 is directed to the thrombectomy device of example 1, wherein the plurality of struts (170) are conjointly coupled to the distal end of the retracting wire.
Example 8 is directed to the thrombectomy device of example 1, wherein the collapsible web is configured to fold into a substantially acicular shape to move within the retraction catheter.
Example 9 is directed to the thrombectomy device of example 1, further comprising a secondary catheter (130) for receiving the retraction catheter (150), the secondary catheter having a collection basket (135) at the distal end thereon.
Example 10 is directed to the thrombectomy device of example 9, wherein the collapsible web and the collection basket cooperate to entrap the clot.
Example 11 is directed to the thrombectomy device of example 1, further comprising a guide wire (140) protruding from the collapsible web, the guide wire configured to penetrate through the clot.
Example 12 is directed to the thrombectomy device of example 1, further comprising a retractor at the proximal end of the thrombectomy device to deploy folding and unfolding of the collapsible ring.
Example 13 is directed to the thrombectomy device of example 9, further comprising a tertiary catheter to receive the retraction catheter and the secondary catheter.
Example 14 is directed to the thrombectomy device of example 1, further comprising an Aligner (1120) coupled to the plurality of struts, wherein release of the Aligner retains the collapsible ring in an open position substantially throughout the retraction phase.
Example 15 is directed to the thrombectomy device of example 14, wherein in the open position the Aligner causes the plurality of struts to remain substantially radially expanded within the body lumen.
Example 16 is directed to a method for extracting a clot (110) from a body lumen, the method comprising: percutaneously accessing the body by inserting a guiding catheter (120) into the body lumen; extending a retraction catheter from the guiding catheter into the body lumen and extending the distal end of the retraction catheter through the clot; extending a retraction wire (160) positioned inside the retraction catheter (150) beyond the distal end of the retraction catheter to thereby cause a plurality of struts (170) coupled to the distal end of the retracting wire to unfold a collapsible web (190); retracting the collapsible web to substantially encircle clot; and retracting the encircled clot into the distal end of the retraction catheter.
Example 17 is directed to the method of example 16, wherein retracting the encircled clot into the distal end of the retraction catheter collapses the web into a substantially acicular structure movable within the retraction catheter.
Example 18 is directed to the method of example 16, wherein the collapsible web (190) further comprises a collapsible ring (180).
Example 19 is directed to the method of example 18, wherein the collapsible ring (180) further comprises a plurality of ring segments (384).
Example 20 is directed to the method of example 16, wherein the collapsible ring (180) communicates with the retracting wire (160) through a plurality of struts (170).
Example 21 is directed to the method of example 20, wherein the plurality of struts (170) are conjointly coupled to the distal end of the retracting wire.
Example 22 is directed to the method of example 16, wherein the step of extending a retraction wire beyond the distal end of the retraction catheter further comprises unfolding a collapsible ring (180) to thereby unfold a collapsible web (190).
Example 23 is directed to the method of example 16, wherein the collapsible ring (180) is configured to assume a substantially circular form when deployed.
Example 24 is directed to the method of example 23, wherein unfolding of the collapsible ring directs expansions of the collapsible web beyond the proximal end of the retraction catheter.
Example 25 is directed to the method of example 16, wherein the collapsible web (190) is configured to fold into a substantially acicular shape to move within the retraction catheter.
Example 26 is directed to the method of example 16, further comprising receiving the retraction catheter (150) at a secondary catheter (130), wherein the secondary catheter (130) further comprises a collection basket (135) at the distal end thereon.
Example 27 is directed to the method of example 26, further comprising entrapping the clot at the collection basket (135).
Example 28 is directed to the method of example 16, wherein the step of extending a retraction wire (160) further comprises opening an Aligner (1120) coupled to the plurality of struts (1106).
Example 29 is directed to the method of example 28, wherein the step of opening the Aligner further causes the collapsible ring to remain in an open position substantially throughout the retraction phase.
Example 30 is directed to the method of example 29, wherein in the open position the Aligner causes the plurality of struts to remain substantially radially expanded within the body lumen.
While the principles of the disclosure have been illustrated in relation to the exemplary embodiments shown herein, the principles of the disclosure are no limited thereto and include any modification, variation or permutation thereof.